Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Chinese Clinical Oncology|September 18, 2017
The optimism surrounding stereotactic body radiation therapy and immunomodulationHannah Tharmalingam, Peter J Hoskin
Nature Reviews. Urology|July 27, 2019
New approaches for effective and safe pelvic radiotherapy in high-risk prostate cancerHannah Tharmalingam, Ananya Choudhury, Marcel Van Herk, et al.
The British Journal of Radiology|November 29, 2019
A pilot study on dosimetric and radiomics analysis of urethral strictures following HDR brachytherapy as monotherapy for localized prostate cancerYat Man Tsang, Dinesh Vignarajah, Alan Mcwilliam, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 25, 2021
Dosimetry of local failure with single dose 19 Gy high-dose-rate brachytherapy for prostate cancerShreya Armstrong, Yatman Tsang, Gerry Lowe, et al.
ESMO Open|November 19, 2020
An evaluation of self-perceived knowledge, attitudes and behaviours of UK oncologists about LGBTQ+ patients with cancerAlison May Berner, Daniel Johnathan Hughes, Hannah Tharmalingam, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 27, 2021
Ultra-hypofractionated radiotherapy for low- and intermediate risk prostate cancer: High-dose-rate brachytherapy vs stereotactic ablative radiotherapyYat Man Tsang, Hannah Tharmalingam, Katherine Belessiotis-Richards, et al.
International Journal of Radiation Oncology, Biology, Physics|October 15, 2019
External Beam Radiation Therapy (EBRT) and High-Dose-Rate (HDR) Brachytherapy for Intermediate and High-Risk Prostate Cancer: The Impact of EBRT VolumeHannah Tharmalingam, Yatman Tsang, Ananya Choudhury, et al.
Pageof 2